Advanced algorithmic patient assessment tools and white-labeled website engagement systems that deliver high-value leads for specialized procedures like uterine fibroid embolization and peripheral arterial disease treatments.
Clients receive over 30 high-quality patient leads monthly and see an increase of 60+ procedures per service line annually through targeted campaigns and data-driven strategies.
Designed by doctors for doctors, with fair lead distribution using geofencing and SEO to direct patients to the most appropriate practices, ensuring growth for all partners.
As Chief Medical Officer at Veras Health, Dr. Morar leads the growth and development of outpatient Interventional Radiology, vascular surgery, and endovascular cardiology programs. His leadership supports the company’s mission to empower physicians and specialty groups to operate independently with clinical and business confidence.
Veras Health provides end-to-end practice support including strategic planning, management services, HR, staffing, branding, and patient development. By focusing on outpatient-based care, the company helps practices deliver efficient, cost-effective treatments outside traditional hospital settings—benefiting both providers and patients.
Pioneered integrated neurological, musculoskeletal and vascular clinical algorithm for minimally invasive treatments. Successfully acquired by Private Equity group in 2020 at 5.8x EBITDA.
Creation of a first of its kind digital platform creating a Uber like platform for Medical Marijuana Patients seeking telehealth consultations with physicians. Expanded out to 4 states with an exit in 2023 at 3 X Revenue
Developed 80% business-to-consumer acquisition strategy with traditional and digital marketing. Merged with regional vascular specialty group in 2019, creating 30% premium for shareholders.
Image guided Laser Liposuction and Cosmetic practice started in a multispecialty structure. Practice growth achieved at 50% per year with direct to consumer marketing strategy. Exit at 5 X EBITDA.
Established hospital-based Interventional Radiology JV with comprehensive interventional spine and vascular services. Successfully divested through structured partner buyout in 2019 at 3 X EBITDA.